Dalargin

10 indexed publications · 1 human studies · research from 1985 to 2021

Research goals studied

  • Cardiovascular
  • Delivery & pharmacokinetics
  • Gut & digestion
  • Infection & antiviral
  • Kidney, liver & organ
  • Neuro & cognition

Studies referencing Dalargin

  • Interaction of Dalargin with Lysozyme

    2021 · Preclinical

    Characterized binding between Dalargin and lysozyme.

  • Hydrophilic Interaction Liquid Chromatography of Dalargin

    2017 · Preclinical

    Developed or validated an analytical method for Dalargin; not an efficacy study.

  • Formulation and Delivery of Dalargin in Nanoparticle Systems

    2008 · Preclinical

    Investigated a formulation strategy intended to improve Dalargin delivery.

  • Oral Brain Targeting of Dalargin Using Nanoparticles

    2005 · Preclinical

    Evaluated nanoparticle-mediated oral delivery and central effects in animals.

  • Nanoparticle-Mediated Brain Uptake of Dalargin

    2003 · Preclinical

    Investigated whether nanoparticle formulations improved brain exposure.

  • Tissue Distribution of Nanoparticle-Associated Dalargin

    2000 · Preclinical

    Measured distribution of Dalargin formulations in vivo.

  • Dalargin in Prevention of Infectious Complications after Heart Surgery

    1994 · Human evidence

    Older clinical report evaluating Dalargin in cardiac-surgery care.

  • Monoclonal Antibodies to Dalargin

    1988 · Preclinical

    Developed or characterized antibodies against Dalargin.

  • NMR and Protease Studies of Dalargin Conformation

    1987 · Preclinical

    Characterized Dalargin structure and proteolytic behavior.

  • Cytoprotective Effects of Dalargin

    1985 · Preclinical

    Early work on opioid-peptide-related cytoprotective activity.

Working with Dalargin?

Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.

Start tracking free